Biosimilars are biologic medications that are developed to be highly similar to an already approved biologic drug, known as the reference product. While biosimilars are developed to be interchangeable with the reference product, there are minor differences in formulations or manufacturing processes compared to the original biologic. For a biosimilar to gain regulatory approval, extensive testing must demonstrate its similarity in purity, potency, and ... Read more
